Rasmussen et al. investigated another key factor in the poor outcome of colon cancer patient, the downregulation of mitogen-activated protein kinase kinase 6 (MAP2K6) by miR-625 and the reduction of p38 signaling linked to the evasion from apoptosis and to L-OHP resistance [59]. Here, MAP2K6 is linked to malignant colon neoplasm.